Background {#Sec1}
==========

Malaria in pregnancy results in an increased risk of low birth weight (LBW) \[[@CR1]--[@CR3]\], maternal anemia and perinatal mortality \[[@CR1], [@CR4]\]. World Health Organization (WHO) has implemented a prevention policy specific to this vulnerable population \[[@CR5], [@CR6]\], based on sulfadoxine-pyrimethamine (SP) intermittent preventive treatment in pregnant women (IPTp) and the use of Long Lasting Impregnated Nets (LLIN) from the onset of pregnancy. The IPTp comprises monthly intakes of a curative dose of SP during antenatal care visits from the second trimester of pregnancy for all pregnant women (whether infected or not). Numerous studies have shown the effectiveness of IPTp in improving maternal and child health outcomes \[[@CR7]--[@CR10]\]. However, IPTp is contraindicated in the first trimester of pregnancy leaving women in the first trimester unprotected by this control tool. Moreover, several studies have shown that the first trimester of pregnancy is a critical period during which malaria infection is associated with an increased risk of low birth weight and maternal anemia \[[@CR11]--[@CR13]\]. LLIN is the only preventive tool available for pregnant women during this period. However, it is known that pregnant women attend the maternity clinic mostly after the first trimester of pregnancy in sub-Saharan Africa \[[@CR14]\]. Consequently, the first trimester of pregnancy is a period badly covered by the malaria prevention policy. There is evidence for the efficacy of LLIN in preventing malaria infection during pregnancy \[[@CR15]\], to improve babies' birth weight \[[@CR16]\]. No study has yet focused on the specific protection conferred by LLIN in the first trimester of pregnancy. In this work, using data from the follow-up of a pre-conceptional cohort carried out in South-Benin in 2015--1016, we evaluated the association between the indicators of use, physical integrity and bio-efficacy of LLINs used by pregnant women and malaria incidence during the first trimester of pregnancy.

Methods {#Sec2}
=======

Study design {#Sec3}
------------

EVALMOUS is a cohort study nested in the RECIPAL project, carried out in South Benin \[[@CR17]\]. Between June 2014 and August 2017, 1214 women of childbearing age and willing to become pregnant (primary cohort) were included in a cohort follow-up. All women were screened for malaria using thick blood smear (TBS) at their inclusion and monitored monthly using a urinary pregnancy test until the identification of 411 pregnant women among them (secondary cohort). The pregnant women were then monitored monthly until delivery at the maternity clinic, where they benefited from a clinical, parasitological (by TBS), nutritional and ultrasound follow-up. Lambarene technique was used to quantify parasitaemia and the detection threshold with this method has been estimated to be 5 parasites/μL \[[@CR18]\]. In addition, in the event of fever or symptoms suggestive to malaria, pregnant women were screened using Rapid Diagnostic Tests (RDT) and treated with Artemisinin-based Combination Therapies (ACT) when tested positive for malaria according to the national guidelines \[[@CR19]\].

EVALMOUS study held between 1st June 2015 and 31st October 2016 and aimed to assess the effectiveness of mosquito nets used by pregnant women and other members of their household in preventing malaria. The first 576 women from the RECIPAL primary cohort who agreed to participate were included in EVALMOUS study before their pregnancy and the first 240 of them to become pregnant were followed throughout the first trimester of pregnancy. Women were visited at three home visits: a first visit was performed before pregnancy and two visits during the first trimester of pregnancy. During these visits, a questionnaire was administered to the women in order to evaluate the indicators related to LLIN, namely: possession, use and physical integrity. At the last visit the mosquito net used by the pregnant women was taken for laboratory testing to assess their bio-efficacy and replaced by new ones provided by the study. Physical integrity and bio-efficacy of the LLINs were determined by the field workers using the standard WHO protocol \[[@CR20]\].

Variables {#Sec4}
---------

### Outcome variable {#Sec5}

Malaria infection during the first trimester of pregnancy was defined as a positive blood smear and/or a positive RDT before 15 weeks of gestation (estimated by early ultrasound scan). Timing of malaria infection was determined based on gestational age.

### Independent variables {#Sec6}

At each visit during the study (before pregnancy and during the first trimester of pregnancy), the use of mosquito net was defined as a binary variable, "good" if LLIN was reported to be used every day of the week preceding the visit and if it was properly installed after inspection by the investigator.

The physical integrity of nets was characterized by a hole index (hi) resulting from the characterization of the holes according to WHO protocol \[[@CR20]\]. A mosquito net with a hi between 0 and 64 was considered as in "good" condition, a hi between 65 and 642 as in an "acceptable" state and a hi greater than 643 as in a "bad" state.

Bio-efficacy of LLIN was based on both kd60 (knock-down 60 min) and 24 h-death (mortality after 24 h) of female *Anopheles gambiae* "Kisumu strain" 2--5 days after exposure to LLIN through standard WHO cone. A LLIN was declared bio-effective when the kd60 rate induced by this LLIN is greater than or equal to 95% or when the mortality rate induced by it is greater than or equal to 80% \[[@CR20]\].

Statistical analysis {#Sec7}
--------------------

First, we did a descriptive analysis of the general characteristic of the women at baseline (sociodemographic, the characteristics of the LLINs and the malaria before pregnancy).

### Univariable analysis {#Sec8}

We studied the relationship between the time to onset of the first malaria infection in the first trimester of pregnancy and each of the independent variables by a univariable Cox regression model. For each covariate, the proportional risk hypothesis was verified using the overall "p" of the Schoenfeld residue-based test. For the continuous covariates, the linearity hypothesis was verified. The comparison between the Kaplan-Meier curves of the different categories of qualitative variables was carried out by a log rank test.

### Multivariable analysis {#Sec9}

The malaria infection and the LLINs indicators were available for 190 pregnant women out of the 240. We compared the 190 pregnant women included in the multivariable analysis and the 50 excluded women according to the age (t-test), the gestational rank, the residence area and the malaria infection before pregnancy. The comparison of the age in the two groups was performed by a t-test whereas the categorical variables were compared using a Chi2 test.

A multivariable Cox regression model was used. Adjustment factors were age (in years) of the pregnant women (quantitative variable recoded in quartiles); the gestational rank (less than 3 pregnancies/more than 3 pregnancies; marital status (unmarried/married); pre-pregnancy malaria infection during the pre-pregnancy visit; ethnicity (Toffin/other); level of education (literate/illiterate); occupational status (employed/unemployed) and residential area (lake area/land area).

First, all covariates were introduced in the model and a backward step-by-step strategy was performed to eliminate non-significant cofactors. At the end of the analysis, only the cofactors associated with the variable to be explained at the 5% *p*-value threshold were retained in the final model in addition to the LLIN indicator variables. As we considered in this study one-sided alternative hypotheses (i.e. better use, better physical integrity and better bio-efficacy would confer protection against malaria), we used one-sided *p*-values with a threshold of significance at 5%.

During the study, six pregnant women had at least 2 malaria infections during the first trimester of pregnancy. In order to assess the determinants of the number of infections, we performed a multivariable Poisson regression model, regressing the same covariates (as in the Cox model) on the number of infections in the first trimester. In addition, in order to take into account the different number of measures between the women, an offset (the log of the number of visits) has been introduced in the model.

The analyses were carried out with STATA software version 13.1 (STATA Corporation, Texas).

Results {#Sec10}
=======

Five hundred and seventy-six pregnant women were included in the EVALMOUS study. Figure [1](#Fig1){ref-type="fig"} shows the flow chart during follow-up of these women. We included 240 pregnant women. At the end of the eighteen months of follow-up, the proportion of drop-out, miscarriages, and refusals was 0.42%; 8.33 and 5% respectively. The bioassays were carried out in the laboratory on 324 LLINs at the end of the first trimester.Fig. 1Flow chart of EVALMOUS study, Benin 2015--2016

The characteristics of the pregnant women included in the study are shown in Table [1](#Tab1){ref-type="table"}. Among the 240 women, the prevalence of malaria infection before pregnancy was 4.41% and the proportion of infected pregnant women during the first trimester of pregnancy was 18.33%. All women except one had an LLIN.Table 1Characteristics of pregnant women at the inclusion, Sô-Ava and Akassato, Benin 2015--2016 (*N* = 240)CharacteristicsPre-pregnancyTotalMean or proportion(95% CI)Age (years)24026.61 ± 4.78Gestational rank240 *Primigravida*229.17 (5.49; 12.84) *Secundigravida*3615.00 (10.45; 19.55) *Multigravida*18275.83 (70.38; 81.29)Ethnic Group240 *Toffin*15665.00 (58.92; 71.08) *Others*8435.00 (28.92; 41.08)Education level240 *Illiterate*16167.08 (61.09; 73.07) *Literate*7932.92 (26.93; 38.90)Occupational status240 *Employed*22192.08 (88.64; 95.52) *Unemployed*197.92 (4.48; 11.36)Marital status240 *Cohabitation*114.58 (1.92; 7.25) *Married (monogamy)*15966.25 (60.22; 72.27) *Married (polygamy)*7029.17 (23.37; 34.96)Residence area240 *Lake area*15665.00 (58.92; 71.08) *Land area*8435.00 (28.92; 41.08)Pre-pregnancy malaria227 *Yes*104.41 (1.72; 7.10) *No*21795.59 (92.90; 98.28)

During pregnancy, all but one of the women had LLINs. Most of pregnant women (83.25%) had used their LLIN properly during the week prior to the visits. About 60% of the LLINs inspected were in good physical condition. On the other hand barely 6% of LLINs tested in the laboratory were bio-effective. Table [2](#Tab2){ref-type="table"} recapitulates the characteristics of the LLIN's indicators inspected.Table 2Indicators of possession, use, physical integrity and chemical efficacy of LLINs inspected during follow-up, Sô-Ava and Akassato, Benin 2015--2016 (N = 240)CharacteristicsPre-pregnancyPregnancy visit 1Pregnancy visit 2TotalMean or proportion (95% CI)TotalMean or proportion (95% CI)TotalMean or proportion (95% CI)Possession of at least one LLIN/household240240203Yes23798.75 (96.17; 97.60)23999.53 (97.06; 99.94)20299.51 (96.53; 99.93)No31.25 (0.40; 3.83)10.42 (0.06; 2.94)10.49 (0.07; 3.47)Possession of LLIN according to WHO standards (1 LLIN/2 people)237239202Yes17875.11 (69.16; 80.23)18577.41 (71.63; 82.30)16481.19 (75.14; 86.03)No5924.89 (19.77; 30.84)5422.59 (17.70; 28.37)3818.81 (13.96; 24.85)Use of LLIN by pregnant women237239202Yes19983.97 (78.69; 89.13)20384.94 (79.78; 88.96)17888.12 (82.83; 91.93)No3816.03 (11.86; 21.31)3615.06 (11.04; 20.22)2411.88 (8.06; 17.17)Physical integrity of pregnant woman's LLIN237239202Good15665.82 (59.51; 71.62)14560.67 (54.29; 66.70)11556.93 (49.95; 63.64)Bad8134.18 (28.38; 40.49)9439.33 (33.30; 45.71)8743.07 (36.36; 50.05)Physical integrity of household's LLIN169195164Good10159.76 (52.12; 66.96)11760.00 (52.91; 66.70)9658.54 (50.77; 77.90)Bad6840.24 (33.04; 47.88)7840.00 (33.30; 47.09)6841.46 (34.10; 49.23)Bio-efficacy of pregnant women's LLIN198Yes----126.06 (3.46; 10.41)No----186Bio-efficacy of household's LLIN126Yes----75.56 (2.64; 11.30)No----11994.44 (88.70; 97.36)

Table [3](#Tab3){ref-type="table"} shows the different proportions of malaria infection during the different visits of the first trimester of pregnancy. The median time between onset of malaria before pregnancy and the beginning of pregnancy was 7.6 months with an interquartile range of (4.9--8.5).Table 3Proportion of pregnant women infected during the first trimester of pregnancy, Sô-Ava and Akassato, Benin 2015--2016Malaria infectionPre-pregnancy visitVisit 1Visit 2Visit 3*n*% (95% CI)*n*% (95% CI)*n*% (95% CI)*n*% (95% CI)Total227234199180Yes104.41 (2.37; 8.03)145.98 (3.56; 9.88)105.02 (2.71; 9.13)179.44 (5.92; 14.73)A total of 239 pregnant women were followed during 626.63 person-months, with a median follow-up time of 88 days (Interquartile interval: 65--95)Table 4Factors associated with the time to onset of the first malaria infection during the first trimester of pregnancy (multivariate Cox model, *N* = 190 pregnant women); Sô-Ava and Akassato, Benin 2015--2016Variables (terms)Multivariatble Cox modelNHRaCI 95%pvalueUse of LLIN by the woman the week before the visit190No361Yes1540.38(0.18--0.80)\< 0.001Physical integrity of the pregnant woman's LLIN190Bad781Good1120.59(0.29--1.19)0.07Quantitative bio-efficacy^a^ of the pregnant woman's LLIN1900.97(0.94--1.00)0.04Malaria before pregnancy190Yes91No1810.27(0.09--0.74)0.01*N* Total, *HRa* Hazard ratio adjusted, *CI 95%* Confidence Interval at 95%, *LLIN* Long Lasting Impregnated bedNets, *pvalue* one-sided pvalue^a^Quantitative bio-efficacy is defined as the proportion of female anopheles who died 24 h after exposure to the LLIN

Figure [2](#Fig2){ref-type="fig"} shows the probability of non-occurrence of malaria infection in pregnant women as a function of time during the first trimester of pregnancy. The incidence rate of malaria infections was 7.18 cases per 100 person-months (95% CI: 5.36--9.62).Fig. 2Probability of non-occurrence of malaria infection in women during the first trimester of pregnancy, Sô-ava and Akassato, Benin, 2015--2016

The group of women not included in the multivariate analysis did not differ significantly from the included pregnant women, according to the 4 variables: age, residence area, gestational rank and malaria before pregnancy (respective *p*-values = 0.48; 0.29; 0.24 and 0.58 respectively). Based on those results, excluding the 50 women from the multivariable model does not seem to have led to a major selection bias.

The variables selected in the final multivariate model respected the proportional hazard asumption assumption according to the Schöenfeld residuals method.

Additional file [1](#MOESM1){ref-type="media"}: Table S1 and Table [4](#Tab4){ref-type="table"} respectively summarize the univariate Cox regression model and the final multivariate Cox model. After adjustment, the use of LLIN by pregnant women was marginally significant, whereas the physical integrity, the LLIN's quantitative bio-efficacy and malaria infection in pre-pregnancy were significantly associated with the time to onset of the first malaria infection in the first trimester of pregnancy.

We also performed a Poisson model to study the effect of the three indicators of LLIN on the number of malaria infections occurring during the first trimester of pregnancy adjusted for the same covariates. In this analysis (Additional file [2](#MOESM2){ref-type="media"}: Table S2), the three indicators of the LLINs (the use, the physical integrity and the quantitative bio-efficacy) were significantly associated with the incidence of malaria infection during the first trimester of pregnancy, (IRRa = 0.40; (0.20--0.78); *p* \< 0.003; IRRa = 0.44; (0.24--0.81); *p* \< 0.004; IRRa = 0.98; (0.95--0.99); *p* \< 0.02 respectively), confirming the results of the Cox model.

Discussion {#Sec11}
==========

The peculiarity of our study was the ability to have followed the women from the pre-conceptional period until the end of the first trimester of pregnancy. This study identified two sets of essential results, i) the refined characterization of the protection given to the pregnant women by the LLIN against malaria infection during the first trimester of pregnancy and ii) new important elements in the reflection on the different indicators of LLIN's efficiency that characterize properly the real protection of pregnant women against malaria during this critical period.

We observed a general high possession and good use of LLIN by the study pregnant women. This is probably an indication of the success of the LLIN mass distribution campaigns carried out previously in Benin in 2011 and 2014. In all, the Cox model confirmed our working hypothesis that the different indicators were significantly related to the delay in malaria infection. Precisely, good use, good physical integrity and the quantitative bio-efficacy of the LLIN were found to be associated with a later occurrence of the first malarial infection during the first trimester of pregnancy. In this model the physical integrity of the LLIN was associated only marginally significantly with the delay of the first malaria infection but showed significant associations in the Poisson regression model. Five pregnant women had malaria infection twice in our study. Two studies did not find any association between LLIN usage by pregnant women and the risk of malaria infection \[[@CR21], [@CR22]\]. Since the effectiveness of LLIN to reduce the malaria burden has been extensively established \[[@CR23]\] including in pregnant women \[[@CR15], [@CR24]--[@CR28]\], those result show probably the limit of the two classical indicators of ownership and reported LLIN use the previous night to characterize adequately the optimal protection of the pregnant woman against the occurrence of a malaria infection. All these elements point out the need to consider, in addition to the classical ownership and reported use indicators, the physical integrity and bio-efficacy indicators should be taken into account in evaluation studies of LLIN efficiency to reduce the malaria burden in pregnant women.

In our study, the high proportions of good use and LLINs with good physical integrity are in favor of a good physical barrier conferred by LLIN to the pregnant women during the first trimester of pregnancy. Nevertheless, a more worrying result was the small minority of LLIN reaching the bio-efficacy threshold set by the WHO recommendations. This raises the highly important question of the duration of the LLINs bio-efficacy in field conditions. Given that optimal protection by the LLIN is provided by the combination of its physical barrier and chemical efficacy, we can conclude that the extreme majority of women in the study were not optimally protected against malaria in the first trimester of their pregnancy by the LLIN they used. This important conclusion would have been missed if only based on the ownership and usage classical indicators.

A strength of our study is that for the first time in a malaria cohort, the women were seen at a pre-conceptional stage which allowed to follow them on the very beginning of their pregnancy. This is an important strenght compared to non preconcepional studies. Although our results indicate minimal selection bias, the moderate size of our sample and the particular facies of the study area (lake zone) impose some caution on the representativeness of the results.

Conclusion {#Sec12}
==========

Our study demonstrated for the first time an overall good physical protection against the malaria vector conferred by LLIN in pregnant women in their first trimester of pregnancy, but low chemical protection in our study area. An important conclusion is that, in addition to the traditional indicator of possession of LLINs by pregnant women, it is essential to take into account other indicators such as actual use, physical integrity and bio-efficiency of LLIN, since all these indicators reflect independently from each other the real protection against malaria of this population. Further studies are then needed to assess the generalizability of our results and also to control the duration of the chemical effectiveness of the LLIN distributed on the territory.
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